FLUORIDE 30 (1)
 1997, pp 51 - 58
International Society for Fluoride Research Table of Contents
Home

Research Report
TOXICITY OF FLUORIDE TO DIABETIC RATS

C A Y Banu Priya, K Anitha, E Murali Mohan, K S Pillai* and P B Murthy
Tamil Nadu, India

SUMMARY: Wistar rats were given 20 ppm fluoride in drinking water, or single administration of 115 mg/kg alloxan i.m. to induce diabetes, or single administration of 115 mg/kg alloxan i.m. followed by 20 ppm fluoride for 31 days. Blood sugar level increased in rats given alloxan and alloxan + fluoride. Body weight gain in rats given alloxan + fluoride decreased significantly compared to other groups. Decrease in haemoglobin and glutamic oxaloacetate transaminase (GOT) was seen only in rats given alloxan + fluoride. In this group alkaline phosphatase, the target enzyme in fluoride toxicosis, increased considerably. The toxicity of fluoride in diabetic rats was further reflected in organ weight data. This investigation shows that fluoride toxicity is greater in diabetic rats.

Key words: Alkaline phosphatase, Body weight, Diabetes mellitus, Fluoride toxicity, Haemoglobin


INTRODUCTION
Endemic fluorosis remains one of the most important water-borne diseases in our country.1 Over 50% of the groundwater sources in India have been contaminated by fluoride. The problem of fluorosis has been reported in various states in India, affecting more than 150,000 villages seriously.2

A survey conducted in 1977 revealed that over two million Indians were affected by diabetes.3 The International Federation of Diabetes and the World Health Organization pointed out the steadily growing incidence of diabetes mellitus and introduced it as a broader based non-communicable disease control programme.4 Diabetes is not a single disease but a heterogeneous group of disorders in glucose intolerance.5 Diabetes mellitus affects anabolic, catabolic and mineral metabolism.6

Considering the large population suffering from diabetes mellitus and the high level of fluoride in 45% of drinking water sources in India,7 it may be presumed that people who suffer from diabetes mellitus may intake abnormal levels of fluoride. To the best of our knowledge, not many studies have been carried out to understand the manifestation of fluoride toxicity in people suffering from diabetes mellitus. In the present investigation, diabetes mellitus (NIDD - non-insulin-dependent diabetes) was induced in rats and thereafter they were exposed to fluoride in drinking water. Body weight changes, organ weights, haematology and blood chemistry were considered in this study.
__________________
* Correspondence: Department of Toxicology, Fredrick Institute of Plant Protection and Toxicology, Padappai 601301, Chengai Anna District, Tamil Nadu, India.


MATERIALS AND METHODS
Female albino rats of Wistar strain (113-133 g) procured from the Institute’s animal house were acclimated to laboratory conditions for 7 days, and divided into 4 groups, each of 4 animals. Group 2 was given: 20 ppm fluoride in drinking water, Group 3 115 mg/kg alloxan i.m. and Group 4 115 mg/kg alloxan i.m. followed by 20 ppm fluoride in drinking water. The control (Group 1) was given only ordinary drinking water.

The fluoride solution was prepared by dissolving an appropriate quantity of NaF (Ranbaxy Laboratories Ltd, Punjab, India) in distilled water. The dose of alloxan (S.d fine-Chem Ltd, Bombay, India) was prepared in sterilized water for injection. Daily body weight gain, feed and water consumption of the animals were recorded.

At the end of the experiment, i.e. on day 32, blood samples were collected from anæsthetised rats from orbital sinus for haematological measurements: white blood corpuscles (WBC), red blood corpuscles (RBC), haemoglobin (HGB), haematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH), mean corpuscular haemoglobin concentration (MCHC) and biochemical investigations (glucose, protein, albumin, globulin, blood urea nitrogen (BUN), creatinine, glutamic pyruvate transaminase (GPT), glutamic oxaloacetate transaminase (GOT) and alkaline phosphatase (ALP).

The animals were sacrificed under anæsthetic ether, and brain, heart, liver, spleen, kidney, gonad and adrenal were isolated for weight determination. haematological parameters were determined on an Erma Particle Counter (Erma Inc, Tokyo, Japan) and the biochemical parameters were estimated using reagent kits (Span Diagnostics, Surat, India) on Erba-Chem-5 plus semiauto analyser (Transasia Biochemicals Ltd, Bombay, India). The data were subjected to a Barlett test for homogeneity, followed by Anova and ‘t’ test.8

RESULTS AND DISCUSSION
Two spontaneous mortalities occurred (one on day 3, the other on day 30) in rats given 115 mg/kg alloxan i.m. (Group 3), and one occurred (on day 31) in rats given 115 mg/kg alloxan i.m. + 20 ppm fluoride in drinking water (Group 4).

The present study does not show any effect on feed consumption of rats treated with fluoride (Group 2) or alloxan (Group 3) or alloxan + fluoride (Group 4) (Table 1). Similar results have been reported when rats were given 10 ppm fluoride in drinking water.9


TABLE 1. Feed and water consumption in control and treated rats

  Group Feed
consumption (g)
Water
consumption (mL)

1 Control 11.28 ± 1.47 17.88  ± 2.78
2 Fluoride 10.93 ± 2.09 15.73  ± 2.18
3 Alloxan 14.15 ± 2.02 36.73* ± 6.49
4 Alloxan + fluoride 16.73 ± 1.44 62.97**± 8.18

Values are mean ± S.D.   *Significantly different from Control (P< 0.05)
**Significantly different from Control as well as Alloxan group (P< 0.05)


An increase in water consumption was recorded in rats given alloxan + fluoride, compared to control animals. Water consumption in rats given alloxan + fluoride was significantly higher than that of the alloxan group. This finding has significance because in an area endemic for hydrofluorosis intake of large quantities of drinking water directly increases fluoride intake. Reports have shown that the intake of excessive amounts of fluoride causes polydipsia.10 Body weight tended to gain in both control and treated groups, though the gain was less in the latter groups. In rats treated with alloxan (Group 3) the body weight gain decreased until day 8, then increased but the rate of increase was less than that of the control and fluoride treated groups. In rats treated with fluoride + alloxen the body weight gain decreased from day 2 of the experiment and these animals did not recover until day 31, when the experiment terminated (Figure 1). It has been shown that fluoride decreases body weight gain in laboratory animals.11,12 The present study shows that a decrease in body weight gain induced by fluoride was greater in diabetic rats, which is further evident from the negative slope of the regression equation (percent body weight gain vs day) (Table 2).


FIGURE 1. Daily percent body weight gain in treated rats
not shown here
please see membership page for information on how to subscribe to FLUORIDE


TABLE 2. Regression equation between body weight (g%/day) and treatment period (day)

Animals Regression equation* R2 S.E. of slope
Control Y = 3.1663 + 0.5992X 0.95 0.0244
Fluoride Y = 2.0860 + 0.6501X 0.91 0.0390
Alloxan Y = 5.3308 + 0.3150X 0.66 0.0418
Diabetes + fluoride Y=11.8876 - 0.1381X 0.46 0.0277

* Y = a + bX: [Y = Body weight gain (g%/day); a = Intercept; b = Slope; X = days]


haematological parameters evaluated in the present study - viz. WBC, MCV, MCH and MCHC were not affected by the treatments, but a decrease in RBC and HCT was evident in rats treated with fluoride, HCT in rats treated with alloxan, and RBC, HGB and HCT in rats treated with alloxan + fluoride. HGB, which was not significantly different from other groups in rats treated with fluoride or alloxan, significantly decreased in those given alloxan + fluoride, which indicates the toxicity to HGB by fluoride in diabetic rats (Table 3). Reports have shown that fluoride decreases RBC and HGB.13,14 However, in the present investigation rats given 20 ppm fluoride (Group 2) did not show any change in these parameters, but in diabetic rats given 20 ppm fluoride they significantly decreased. This result indicates that diabetic rats are prone to exhibit alterations in RBC and HGB in fluoride toxicosis.

TABLE 3. Haematology of control and treated rats

Group WBC
(X103µL)
RBC
(X106µL)
HGB
(g/dL)
HCT
(%)
MCV
(fL)
MCH
(pg)
MCHC
(g/dL)

Control (n=4) 8.25
±2.1
7.15
±1.37
14.89
±2.99
41.69
±9.51
55.83
±1.59
20.75
±1.35
37.28
±2.41
Fluoride (n=4) 8.53
±3.59
5.49*
±1.01
12.42
±3.25
28.81*
±4.98
53.24
±4.42
19.98
±1.61
38.40
±2.87
Alloxan (n=2) 8.50
±4.67
5.81
±1.46
11.85
±3.54
29.93*
±8.80
51.34
±2.29
20.20
±1.13
37.75
±2.76
Alloxan +
fluoride (n=3)
6.97
±2.51
4.43*
±0.93
9.12*
±2.09
25.00*
±7.70
53.90
±2.46
22.77
±3.42
39.17
±4.78

Values are mean ± S.D. * Significantly different from control (P<0.05)


Administration of 115 mg/kg alloxan i.m. significantly increased blood glucose level. Induction of diabetes mellitus which reflects an increase in blood sugar level by the administration of alloxan has been studied by several workers.15 In rats treated with alloxan + fluoride the blood sugar increased, compared with that of control, but it was on a par with that of the rats treated with alloxan (Table 4).

A significant increase in protein and globulin observed in rats given fluoride and those given alloxan + fluoride may indicate hepatic disorders.16 An increase in protein was reported in ventral prostate of rats given 10 mg/kg b.w. fluoride orally for 30 days.17 BUN significantly increased in rats given alloxan and those given alloxan + fluoride, whereas creatinine was unaffected in any of the treated groups compared to that of control. An increase in BUN which may be due to renal dysfunction is another characteristic change in diabetes.18 An increase in GPT was evident in rats given alloxan but in those given alloxan + fluoride the GPT level was similar to that of control animals. GOT significantly decreased in the alloxan + fluoride group. It has been shown that 10 ppm of fluoride given in drinking water for 12 weeks decreased GOT in rabbits.19 However, in the present study rats given 20 ppm of fluoride (Group 2) did not show any change in GOT level. The decline of GOT in rats given alloxan + fluoride (Group 4) may suggest the magnification of fluoride toxicity in diabetic rats as also indicated by alkaline phosphatase, which has been reported as the target enzyme in fluoride toxicosis.20 Higher activity of serum alkaline phosphatase reflects abnormal formation of bone due to stimulated osteoblastic activity as suggested by Blood and Radostits.21 In the present study, alkaline phosphatase level in fluoride-treated rats (Group 2) significantly rose and the level shot up in diabetic rats given fluoride (Group 4).

Pathological findings of the present study also indicate toxicological magnification by fluoride in diabetic rats. Weight ratios of adrenals and kidneys significantly increased compared to those of control (Table 5). Both diabetes 22 and fluorosis 23 are major disorders which affect several organ systems. It may be concluded from the present study that toxicity by fluoride is greater in diabetes.

Acknowledgments: We are grateful to the management of the Fredrick Institute of Plant Protection and Toxicology for the laboratory facilities. Mrs B Sujatha and Mr T Ramakrishnan typed the manuscript.

REFERENCES

  1. Pillai KS. Biological magnification of fluoride toxicity. Proceedings, Assessment of Environmental Pollution. Academy of Environmental Biology, Aurungabad (India) 1985 pp 135-141.
  2. Teotia SPS, Teotia M. Endemic fluoride: Bone and teeth - update. Indian Journal of Environmental Toxicology 1 (1) 1-6 1991.
  3. Report of the Expert Groups. Indian Council of Medical Research, New Delhi 1977.
  4. King H, Gruber W, Lander T (Eds). Implementing National Diabetics Programmes - Report of a WHO Meeting. World Health Organization, Geneva 1995.
  5. Salans LB. The variability of diabetes mellitus. In: Diabetes Mellitus. Academic Press, London 1989 pp 1-13.
  6. Thruston JH, McDougal DB Jr, Schulz HRE. Effect of acute, subacute and chronic diabetes on carbohydrate and energy metabolism in rat sciatic nerve: Relation to mechanism of peripheral neuropathy. Diabetes 44 (2) 190-195 1995.
  7. Teotia SPS, Teotia M. Endemic fluorosis in India: A Challenging National Health Problem. Journal of Association of Physicians, India 32 347-352 1984.
  8. Anderson D, Conning DM. Experimental Toxicology - The Basic Issue. Royal Society of Chemistry, Cambridge 1993 pp 405-440.
  9. Pillai KS, Murthy PB. Toxicity of combination of fluoride and ethanol to rat. Indian Journal of Toxicology 102 69-72 1994.
  10. Sauerbrunn BJL, Ryan CM, Shaw JF. Chronic fluoride intoxication with fluorotic radiculomyelopathy. Annals of Internal medicine 63 1074-1078 1965.
  11. Buttner W, Karle E. Chronic toxicity and retention of fluoride in the unilaterally nephrectomized rat. Caries Research 8 359-367 1974.
  12. Pillai KS, Mathai AT, Deshmukh PB. Effect of subacute dosage of fluoride on male mice. Toxicology Letters 44 21-29 1988.
  13. Kahl S, Wojcik K, Ewy Z. Effect of fluoride on some haematological indices and iron-59 distribution in the blood and iron storing tissues of rats. Bulletin of Academy of Poland Science Series in Biology 21 389-393 1973.
  14. Pillai KS, Mane UH. Effect of airborne fluoride on some haematological parameters of chick. Bulletin of Environmental Contamination and Toxicology 33 510-516 1985.
  15. Makar TK, Hungand BL, Cook CA et al. Lipid metabolism and membrane composition are altered in brains of type II diabetic mice. Journal of Neurochemistry 64 2159-2168 1995.
  16. Davidsohn I, Henry JB. Clinical Diagnosis by Laboratory Methods. McMillan India, New Delhi 1977.
  17. Chinoy NJ, Pradeep PK, Sequeira E. Effect of fluoride ingestion on the physiology of reproductive organs of male rats. Journal of Environmental Biology 13 (1) 55-61 1992.
  18. Varley H. Diabetes mellitus, ketosis, diabetic coma. In: Practical Clinical Biochemistry. Central Book Society, New Delhi 1988.
  19. Ferguson DB. The effects of low doses of fluoride on enzyme activity in rabbit serum. Archives of Oral Biology 21 449-450 1976.
  20. Singh JL, Swalup D. Fluorosis in buffaloes. Veterinary Research 135 260 1994.
  21. Blood DC, Radostits UM. Veterinary Medicine. (7th edition). English Language Book Society/Bailliere Tindall, London 1984.
  22. Mendez JD, Romes HG. Animal models in diabetic research. Archives in Medical Research 25 67-75 1994.
  23. Chinoy NJ. Effects of fluoride on physiology of animals and haematology. Indian Journal of Environmental Toxicology 1 (1) 17-32 1994.

Fluoride Vol.30 No.1 1997
Published by the International Society for Fluoride Research


FLUORIDE 30 (1)
 1997, pp 51 - 58
International Society for Fluoride Research
Home | Table of Contents | ISFR Board | Subscription
Submissions | Announcements | Authors | Subject Index